CEO Seunghoon Choi increases stake by 0.09%p via open market purchase... small but positive insider confidence signal


  • CEO Seunghoon Choi acquired 3,500 common shares at 6,750 won per share via open market purchase on May 29, 2026.
  • This increased his ownership from 0.80% to 0.89%, a 0.09 percentage point rise.
  • The purchase price (6,750 won) is 1.5% above the closing price on the base date (6,650 won on May 28), which can be interpreted as management's belief in undervaluation and a positive signal.
  • However, the purchase size is only 0.09% of total outstanding shares, so the short-term impact on stock price is limited.
  • [AI Comprehensive Analysis]This disclosure shows a small insider purchase, indicating management confidence but unlikely to significantly change shareholder value. Continued monitoring of further purchases and disclosures is recommended.

KOSDAQ Filing Information


  • Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: Daesung Microbiological Labs (036480)
  • Submission: Seunghoon Choi
  • Receipt: 05-29-2026